Agilent Focuses on Workflows As It Eyes Benefits of Stratagene Buy, Revenue Growth | GenomeWeb
This story originally appeared in Biocommerce Week, a newsletter that has been discontinued.
Agilent Technologies intends to continue focusing on building workflows for customers rather than aiming to be a one-stop shop for life science researchers, company officials said last week during the firm’s Bio-Analytical Measurement Investor Forum, which was webcast live from its facilities in Wilmington, Del.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

An opinion piece in the New York Times urges lawmakers to keep genetic protections in place.

Research funding in Canada is to remain mostly the same, ScienceInsider reports.

In Science this week: random DNA replication errors play role in cancer, and more.

The Bill and Melinda Gates Foundation embarks on an open-access publishing path.